Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q96M32
UPID:
KAD7_HUMAN
Alternative names:
ATP-AMP transphosphorylase 7
Alternative UPACC:
Q96M32; Q8IYP6
Background:
Adenylate kinase 7, also known as ATP-AMP transphosphorylase 7, plays a crucial role in cellular energy homeostasis by catalyzing the transfer of phosphate groups between nucleoside triphosphates and monophosphates. It exhibits the highest activity towards AMP and is involved in maintaining ciliary structure and function, highlighting its importance in cellular mechanics and signaling.
Therapeutic significance:
The protein's association with Spermatogenic failure 27, a disorder characterized by defects in spermatogenesis leading to abnormal sperm flagella, underscores its potential as a target for therapeutic intervention. Understanding the role of Adenylate kinase 7 could open doors to potential therapeutic strategies for treating infertility issues related to spermatogenic defects.